Literature DB >> 9672758

Interleukin-2 and its effects in the central nervous system.

C L Jiang1, C L Lu.   

Abstract

Interleukin-2 (IL-2) is not only an important immunoregulatory molecule: it is also an important neuroregulatory molecule in the CNS. Investigations in vivo and in vitro have elucidated the following: IL-2 and IL-2 receptors (IL-2R) have been detected in the brain; IL-2 promotes survival and neurite extension of cultured neurons, stimulates oligodendrocyte proliferation and maturation, affects the hypothalamic-pituitary function and produces behavioral and electrocorticogram spectrum changes. Investigations in some laboratories, including ours, have also demonstrated an analgesic effect of IL-2 in the CNS. The molecular structure of the analgesic domain of IL-2 is distinct from the immune domain mediating immunoregulatory effects. A possible mechanism of action of cytokines on the CNS and the immune system or both exists: multiple actions of cytokines could be mediated by distinct domains or functional sites of cytokines interacting with different receptors or receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672758     DOI: 10.1159/000014541

Source DB:  PubMed          Journal:  Biol Signals Recept        ISSN: 1422-4933


  8 in total

Review 1.  Viral vector-based gene transfer for treatment of chronic pain.

Authors:  Shuanglin Hao; Marina Mata; David J Fink
Journal:  Int Anesthesiol Clin       Date:  2007

2.  Neuroinflammation in psychiatric disorders: An introductory primer.

Authors:  Geoffrey A Dunn; Jennifer M Loftis; Elinor L Sullivan
Journal:  Pharmacol Biochem Behav       Date:  2020-07-01       Impact factor: 3.533

3.  The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas.

Authors:  D Figarella-Branger; L Daniel; P André; S Guia; W Renaud; G Monti; E Vivier; G Rougon
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.

Authors:  Calliope A Dendrou; Linda S Wicker
Journal:  J Clin Immunol       Date:  2008-09-09       Impact factor: 8.317

5.  The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.

Authors:  Dominique Musselman; Erica B Royster; Ming Wang; Qi Long; Lisa M Trimble; Tara K Mann; Daniel S Graciaa; Marcia D McNutt; N S Freda Auyeung; Lindsay Oliver; David H Lawson; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2013-04-10       Impact factor: 7.853

6.  Integrative Analysis of lncRNA and mRNA and Profiles in Postoperative Delirium Patients.

Authors:  Yuxiang Song; Xiaoyan Wang; Aisheng Hou; Hao Li; Jingsheng Lou; Yanhong Liu; Jiangbei Cao; Weidong Mi
Journal:  Front Aging Neurosci       Date:  2021-05-19       Impact factor: 5.750

7.  Pre-Operative, High-IL-6 Blood Level is a Risk Factor of Post-Operative Delirium Onset in Old Patients.

Authors:  Miriam Capri; Stella Lukas Yani; Rabih Chattat; Daniela Fortuna; Laura Bucci; Catia Lanzarini; Cristina Morsiani; Fausto Catena; Luca Ansaloni; Marco Adversi; Maria Rita Melotti; Gianfranco Di Nino; Claudio Franceschi
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-17       Impact factor: 5.555

8.  Four Cysteine Residues Contribute to Homodimerization of Chicken Interleukin-2.

Authors:  Chen Deng; Hailiang Tan; Hongda Zhou; Mengyun Wang; Yan Lü; Jiacui Xu; Huanmin Zhang; Limei Han; Yongxing Ai
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.